Associated Papers
[18F]florbetapir PET for early detection of amyloidosis in patients with hereditary transthyretin amyloidosis polyneuropathy.
Kong Y et al.
Genes & Diseases, 2026
A shared amyloid fold in cardiac fibrils from three neuropathy-associated ATTR variants.
Fernandez-Ramirez MDC et al.
Structure (london, England : 1993), 2026
Efficacy of Suppression of Serum Transthyretin With Patisiran and Vutrisiran in Variant ATTR Amyloidosis: An Observational Crossover Study.
Razvi Y et al.
Circulation, 2026
The causative role of amyloidosis in the cardiac complications of Alzheimer's disease: a comprehensive systematic review.
Parker S et al.
The Journal of Physiology, 2026
Hereditary Polyneuropathies in the Era of Precision Medicine: Genetic Complexity and Emerging Strategies.
Chrysostomaki M et al.
Genes, 2026
Clinical Utility of Serum Neurofilament Light Chain in Peripheral Neuropathy.
Karam C
Muscle & Nerve, 2026
Transthyretin Cardiac Amyloidosis With Reduced Ejection Fraction in a 47-Year-Old Man: An Unusual Presentation.
Moujahid M et al.
Cureus, 2026
Relationship between amyloid choroidopathy and neurological involvement severity scores in transthyretin amyloidosis.
Hamoudi L et al.
Journal Francais D'ophtalmologie, 2025
Predictors of poor prognosis in a large cohort of patients with hereditary cardiac transthyretin amyloidosis.
Ripoll-Vera T et al.
Revista Espanola De Cardiologia (english Ed.), 2025
The Vagal Link: Autonomic Nervous System Dysfunction in Cardiac Amyloidosis.
Barocelli F et al.
Journal of Clinical Medicine, 2025
Structure of ATTRv-F64S fibrils isolated from skin tissue of a living patient.
Yu J et al.
Nature Communications, 2025
Structural and molecular homogeneity of ATTRv-T60A amyloid fibrils across patients and organs.
Fernandez-Ramirez MDC et al.
Structure (london, England : 1993), 2025
Transthyretin cardiac amyloidosis: advances and ambiguities.
Danilov A et al.
Heart Failure Reviews, 2025
Impact of patisiran on polyneuropathy of hereditary transthyretin amyloidosis in patients with a V122I or T60A variant: a phase IV multicenter study.
Hussain Y et al.
Annals of Medicine, 2025
Transthyretin Cardiac Amyloidosis and Heart Failure: State-of-the-Art Review and Practice Guidance.
Bukhari S et al.
Reviews in Cardiovascular Medicine, 2025
Human-Induced Pluripotent Stem Cell Models for Amyloid Cardiomyopathy: From Mechanistic Insights to Therapeutic Discovery.
Liu Y et al.
Journal of Cardiovascular Development and Disease, 2025
Effectiveness and Utility of Genetic Testing in Establishing a Diagnosis of Hereditary Transthyretin Amyloidosis.
Singh A et al.
Journal of Clinical Medicine, 2025
Integrative structural profiling and ligand optimisation across the transthyretin mutational landscape.
Lomoio U et al.
Npj Systems Biology and Applications, 2025
Transthyretin immunohistochemistry on muscle and nerve biopsies detects hereditary and wild-type transthyretin amyloidosis with high sensitivity and specificity.
Elnagdy M et al.
Journal of Neuropathology and Experimental Neurology, 2025
Covert Transthyretin Amyloidosis Mimicking Advanced Obstructive Hypertrophic Cardiomyopathy Despite Multiple Negative 99mTc-PYP Radionuclide Scans.
Reuter M et al.
Jacc. Case Reports, 2025
Genetic and clinical features of hereditary transthyretin amyloidosis: a decade of experience at a Japanese referral center.
Nomura T et al.
Orphanet Journal of Rare Diseases, 2025
Early cardiovascular autonomic failure in ATTRv predicts poor prognosis and may respond to disease-modifying therapy.
Sander L et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis, 2025
Skin Biopsy as a Diagnostic Tool for ATTRv Amyloid Neuropathy in the UK.
O'Donnell LF et al.
Journal of the Peripheral Nervous System : Jpns, 2025
Effect of G83R Mutation on Transthyretin Protein Structural Stability.
Chen X et al.
Acs Omega, 2025
A Shared Amyloid Architecture in Cardiac Fibrils from Three Neuropathy-Associated ATTR Variants.
Fernandez-Ramirez MDC et al.
Biorxiv : the Preprint Server for Biology, 2025
Peripheral Nervous System Involvement of Hereditary Transthyretin Amyloidosis in the United States: A Multi-Center Perspective.
Desai U et al.
Muscle & Nerve, 2025
Uncertain Clinical Relevance of Serial Bone Scintigraphy Findings in Treated Transthyretin Amyloid Cardiomyopathy.
Razvi Y et al.
Jacc. Cardiovascular Imaging, 2025
Phenotypic Presentation and Longitudinal Characterization of Hereditary ATTRv Amyloidosis in Previously Undiagnosed Family Members.
Fazzini L et al.
Jacc. Advances, 2025
Transthyretin amyloid deposition in the ligamentum flavum of an Italian cohort of patients with lumbar spinal stenosis.
Vitali F et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2025
Early Detection of Transthyretin Cardiac Amyloidosis Using 124I-Evuzamitide Positron Emission Tomography/Computed Tomography.
Smiley DA et al.
Jacc. Cardiovascular Imaging, 2025
Impact of mechanical stress on human transthyretin protein amyloid formation.
You M et al.
International Journal of Biological Macromolecules, 2025
A Multicenter Study of Hereditary Transthyretin Amyloidosis in China.
Chu X et al.
Annals of Neurology, 2025
Therapeutic effect of TTR siRNA on hereditary transthyretin amyloidosis (ATTRv) nephropathy.
Ajiki T et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis, 2025
Cognitive manifestations and brain integrity in hereditary transthyretin amyloidosis: a systematic review.
Senem I et al.
Journal of Neurology, 2025
Pharmacological Management of Transthyretin Amyloid Cardiomyopathy: Where We Are and Where We Are Going.
De Michieli L et al.
Journal of Clinical Medicine, 2025
The contribution of genetics to the understanding and management of cardiomyopathies: Part 2.
Cardoso I et al.
Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology, 2025
Diagnosis and Management of Mixed Phenotype Hereditary Transthyretin Amyloidosis: A Case-Based, Canadian Perspective.
Fine N et al.
Cjc Open, 2025
Hereditary transthyretin amyloidosis (ATTRv).
Triposkiadis F et al.
Current Problems in Cardiology, 2025
Intraepineurial Fat Fraction: A Novel MR Neurography-Based Biomarker in Transthyretin Amyloidosis Polyneuropathy.
Cruz ES et al.
European Journal of Neurology, 2025
Oxidative conversion of transthyretin in formalin-fixed clinical amyloid samples results in the formation of the His90Asp and His90Asn variants.
Raheja S et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis, 2025
Hereditary Transthyretin Amyloidosis in Israel: Genetic Landscape and Clinical Characteristics.
Dori A et al.
European Journal of Neurology, 2025
Transthyretin Cardiac Amyloidosis in Australia and New Zealand-A Multi-Site Snapshot for 2022.
Geenty P et al.
Heart, Lung & Circulation, 2025
A case series of patients with cardiac amyloidosis evaluated at a Colombian university hospital.
López-Ponce de León JD et al.
Frontiers in Cardiovascular Medicine, 2025
Transthyretin-related amyloid cardiomyopathy: A single-center experience in southern Poland, an endemic area.
Holcman K et al.
Kardiologia Polska, 2025
His108Arg Transthyretin Amyloidosis-Shedding Light on a Distinctively Malignant Variant.
Binder C et al.
Journal of Clinical Medicine, 2024
Management of Hereditary Transthyretin Amyloidosis (ATTRv) Patients and Asymptomatic Carriers in Spain: The EMPATIa Study.
Losada López I et al.
Journal of Clinical Medicine, 2024